On the filings, American Tower (AMT) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.
High-quality global tower REIT with durable recurring cash flow, but full multiple, heavy leverage, and two live customer disputes cap upside.
Cash-generative tower REIT with a covered dividend, but Sprint-driven revenue decline and a full valuation cap the upside — hold.
| Metric | AMT | CCI |
|---|---|---|
| Fundamentals score | 81 | 73 |
| Revenue growth (YoY) | +20.8% | +12.0% |
| Net income growth (YoY) | +15.3% | +111.4% |
| Net margin | 280.9% | 206.5% |
| Return on equity | 72.0% | — |
| ROIC (est.) | 8.3% | — |
| Liabilities / Equity | 14.47 | -20.28 |
| Piotroski F-score | 7 / 9 | 5 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 11:13 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 19, 2026, 8:21 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.